A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Carcinoma, Renal Cell|Kidney Diseases|Kidney Neoplasms|Urogenital Neoplasms|Urologic Diseases|Urologic Neoplasms|Neoplasms by Histologic Type|Neoplasms|Clear-cell Metastatic Renal Cell Carcinoma|Melanoma|Triple Negative Breast Cancer|Bladder Cancer|Head and Neck Cancer|Non-small Cell Lung Cancer
Interventions: DRUG: Combination of Varlilumab and Atezolizumab
Sponsor: Celldex Therapeutics
Collaborators: Genentech, Inc.